FDA-approved
Bones & muscles
Parathyroid hormone
Evidence
FDA approved
Class
Parathyroid hormone, an 84-amino-acid hormone
KEY TAKEAWAY
Parathyroid hormone (PTH) is an 84-amino-acid hormone that controls calcium in the blood. A recombinant form was sold as Natpara. The FDA approved recombinant PTH (Natpara) in 2015 for hypoparathyroidism. The manufacturer discontinued it at the end of 2024.
Written by the Veylo editorial team · Updated
November 2026
What it is
Parathyroid hormone, an 84-amino-acid hormone
Approved for
Hypoparathyroidism
Key fact
The FDA approved recombinant PTH (Natpara) in 2015 for hypoparathyroidism. The manufacturer discontinued it at the end of 2024.
Route
Daily subcutaneous injection
Evidence strength
FDA approved
Parathyroid hormone (PTH) is an 84-amino-acid hormone that controls calcium in the blood. A recombinant form was sold as Natpara.
It raises blood calcium by acting on bone and kidney and, indirectly, on the gut.
The FDA approved recombinant PTH (Natpara) in 2015 for hypoparathyroidism. The manufacturer discontinued it at the end of 2024.
Hypoparathyroidism.
High or low blood calcium were the main risks. The label carried a boxed warning about osteosarcoma seen in rats.
U.S. FDA prescribing information for Parathyroid hormone. DailyMed, National Library of Medicine.
Veylo content is educational and not medical advice. Peptides that are not FDA-approved are not approved for the uses described.